S&P 500   2,990.72 (-0.24%)
DOW   26,849.53 (-0.65%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
S&P 500   2,990.72 (-0.24%)
DOW   26,849.53 (-0.65%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
Log in

Vectura Group News Headlines (LON:VEC)

GBX 86.30
-2.96 (-3.32 %)
(As of 10/18/2019 02:18 PM ET)
Today's Range
86.10
Now: GBX 86.30
93
50-Day Range
77.05
MA: GBX 83.06
89.26
52-Week Range
65.85
Now: GBX 86.30
90.15
Volume369,961 shs
Average Volume4.61 million shs
Market Capitalization£575.02 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Vectura Group (LON VEC) News Headlines

Source:
DateHeadline
Vectura Group (LON:VEC) PT Lowered to GBX 114 at Peel HuntVectura Group (LON:VEC) PT Lowered to GBX 114 at Peel Hunt
www.americanbankingnews.com - September 24 at 9:35 AM
Vectura Group plc - Vectura provides update on GSK LitigationVectura Group plc - Vectura provides update on GSK Litigation
www.lse.co.uk - September 13 at 12:04 PM
US Judge Awards Supplemental Damages To Vectura In Glaxo CaseUS Judge Awards Supplemental Damages To Vectura In Glaxo Case
www.morningstar.co.uk - September 13 at 12:04 PM
Vectura provides update on GSK LitigationVectura provides update on GSK Litigation
www.marketwatch.com - September 13 at 12:04 PM
BRIEF-Vectura Group Proposed Special Dividend And Share Consolidation, Share Buyback Programme And Dividend Reinvestment PlanBRIEF-Vectura Group Proposed Special Dividend And Share Consolidation, Share Buyback Programme And Dividend Reinvestment Plan
www.msn.com - September 10 at 11:54 PM
Vectura delivers strong financial performance for H1 2019 and confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programmeVectura delivers strong financial performance for H1 2019 and confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme
finance.yahoo.com - September 10 at 6:53 PM
Edited Transcript of VEC.L earnings conference call or presentation 10-Sep-19 8:30am GMTEdited Transcript of VEC.L earnings conference call or presentation 10-Sep-19 8:30am GMT
finance.yahoo.com - September 10 at 6:53 PM
Vectura Group declares GBP 0.06 dividendVectura Group declares GBP 0.06 dividend
seekingalpha.com - September 10 at 1:51 PM
Vectura Proposes Capital Return Amid "Strong" Interim Revenue GrowthVectura Proposes Capital Return Amid "Strong" Interim Revenue Growth
www.morningstar.co.uk - September 10 at 1:51 PM
Vectura Group plc 2019 Q2 - Results - Earnings Call SlidesVectura Group plc 2019 Q2 - Results - Earnings Call Slides
seekingalpha.com - September 10 at 1:51 PM
Vectura Group plc: Proposed Special Dividend and Share Consolidation, Share Buyback Programme and Dividend Reinvestment PlanVectura Group plc: Proposed Special Dividend and Share Consolidation, Share Buyback Programme and Dividend Reinvestment Plan
www.marketwatch.com - September 10 at 1:51 PM
Smart Inhalers Market Insight, Trends, Outlook By Key Players | GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AGSmart Inhalers Market Insight, Trends, Outlook By Key Players | GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG
www.marketwatch.com - August 29 at 10:28 AM
Smart Inhalers Market Size, Share, Trends, Scope, Growth Opportunity and Forecast, 2014 – 2024Smart Inhalers Market Size, Share, Trends, Scope, Growth Opportunity and Forecast, 2014 – 2024
www.marketwatch.com - August 19 at 10:08 AM
Dry Powder Inhaler Market Appearing Growth & Worldwide Industry Forecast to 2028!Dry Powder Inhaler Market Appearing Growth & Worldwide Industry Forecast to 2028!
www.marketwatch.com - August 18 at 9:51 AM
Global Dry Powder Inhaler Market 2019-2026 : Astrazeneca, 3M, GlaxoSmithKline, Novartis, Cipla LtdGlobal Dry Powder Inhaler Market 2019-2026 : Astrazeneca, 3M, GlaxoSmithKline, Novartis, Cipla Ltd
www.marketwatch.com - August 16 at 10:44 PM
Asthma and COPD Drug Market Research Study, Global Industry Analysis, Future Trends and Forecast, 2019 – 2026Asthma and COPD Drug Market Research Study, Global Industry Analysis, Future Trends and Forecast, 2019 – 2026
www.marketwatch.com - August 15 at 10:24 PM
Inhalers Market Industry Analysis By Growth, Size, Share, Competitive Overview, Opportunities, Key Players, And Region With Forecast 2019-2026Inhalers Market Industry Analysis By Growth, Size, Share, Competitive Overview, Opportunities, Key Players, And Region With Forecast 2019-2026
www.marketwatch.com - August 13 at 5:51 PM
Vectura Group plc (LON:VEC): When Will It Breakeven?Vectura Group plc (LON:VEC): When Will It Breakeven?
finance.yahoo.com - August 7 at 11:34 AM
Vectura Confirms Annual Outlook; Plans GBP50 Million Shareholder AwardVectura Confirms Annual Outlook; Plans GBP50 Million Shareholder Award
www.morningstar.co.uk - July 17 at 10:31 AM
Vectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pre-close trading updateVectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pre-close trading update
finance.yahoo.com - July 17 at 10:31 AM
Do Institutions Own Vectura Group plc (LON:VEC) Shares?Do Institutions Own Vectura Group plc (LON:VEC) Shares?
finance.yahoo.com - June 20 at 10:09 AM
Vectura Chief Executive To Leave; Finance Head Named As Interim CEOVectura Chief Executive To Leave; Finance Head Named As Interim CEO
www.morningstar.co.uk - June 10 at 10:55 AM
2 ‘hidden’ healthcare stocks I would buy and hold2 ‘hidden’ healthcare stocks I would buy and hold
www.msn.com - June 5 at 9:56 AM
Vectura Group On Track, Confident On Prospects For Rest Of 2019Vectura Group On Track, Confident On Prospects For Rest Of 2019
www.morningstar.co.uk - May 29 at 9:59 AM
BRIEF-Vectura Group To Receive $2.5 Mln Milestone Payment For QVM149 SubmissionBRIEF-Vectura Group To Receive $2.5 Mln Milestone Payment For QVM149 Submission
www.reuters.com - May 24 at 10:13 AM
Vectura Gets Milestone Payment On Novartis Submission Of Asthma DrugVectura Gets Milestone Payment On Novartis Submission Of Asthma Drug
www.morningstar.co.uk - May 24 at 10:13 AM
TOP NEWS SUMMARY: China Vice Premier Heads To US As Trade Talks WobbleTOP NEWS SUMMARY: China Vice Premier Heads To US As Trade Talks Wobble
www.morningstar.co.uk - May 7 at 10:00 AM
TOP NEWS: Vectura Wins Patent Litigation Against GlaxoSmithKlineTOP NEWS: Vectura Wins Patent Litigation Against GlaxoSmithKline
www.morningstar.co.uk - May 7 at 10:00 AM
UKs Vectura wins patent infringement case against GlaxoSmithKline in U.SUK's Vectura wins patent infringement case against GlaxoSmithKline in U.S
finance.yahoo.com - May 4 at 4:27 PM
Is There An Opportunity With Vectura Group plcs (LON:VEC) 21% Undervaluation?Is There An Opportunity With Vectura Group plc's (LON:VEC) 21% Undervaluation?
finance.yahoo.com - May 1 at 9:52 AM
Is There An Opportunity With Vectura Group plc's (LON:VEC) 21% Undervaluation?Is There An Opportunity With Vectura Group plc's (LON:VEC) 21% Undervaluation?
finance.yahoo.com - May 1 at 9:52 AM
Edited Transcript of VEC.L earnings conference call or presentation 26-Mar-19 9:30am GMTEdited Transcript of VEC.L earnings conference call or presentation 26-Mar-19 9:30am GMT
finance.yahoo.com - March 26 at 5:47 PM
Vectura Reports Revenue Growth In 2018 But Loss Widens On Higher CostsVectura Reports Revenue Growth In 2018 But Loss Widens On Higher Costs
www.morningstar.co.uk - March 26 at 10:24 AM
More on Vectura Group FY resultsMore on Vectura Group FY results
seekingalpha.com - March 26 at 10:24 AM
Vectura Group plc 2018 Preliminary Results    Vectura Group plc 2018 Preliminary Results    
finance.yahoo.com - March 26 at 10:24 AM
Pieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q4 2018 Results - Earnings Call TranscriptPieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 5:00 PM
Have Insiders Been Buying Vectura Group plc (LON:VEC) Shares?Have Insiders Been Buying Vectura Group plc (LON:VEC) Shares?
finance.yahoo.com - January 17 at 11:16 AM
Vectura Expects Revenue To Be In Line, EBITDA Materially Above Market ViewVectura Expects Revenue To Be In Line, EBITDA Materially Above Market View
www.finanznachrichten.de - January 3 at 10:03 AM
UK Drugmaker Vectura Expects 2018 Earnings to Top Market ForecastsUK Drugmaker Vectura Expects 2018 Earnings to Top Market Forecasts
www.nytimes.com - January 3 at 10:03 AM
Vectura hopes new inhalers will breathe life into businessVectura hopes new inhalers will breathe life into business
finance.yahoo.com - January 3 at 10:03 AM
Vectura loses UK court case vs. Glaxo on patentsVectura loses UK court case vs. Glaxo on patents
www.marketwatch.com - December 13 at 8:44 AM
What Investors Should Know About Vectura Group plc’s (LON:VEC) Financial StrengthWhat Investors Should Know About Vectura Group plc’s (LON:VEC) Financial Strength
finance.yahoo.com - November 29 at 10:16 AM
WINNERS & LOSERS SUMMARY: Vectura Slides On Asthma Treatment FailureWINNERS & LOSERS SUMMARY: Vectura Slides On Asthma Treatment Failure
www.morningstar.co.uk - November 26 at 9:47 AM
Vectura Discontinues VR375 As Phase Three Study Misses EndpointsVectura Discontinues VR375 As Phase Three Study Misses Endpoints
www.morningstar.co.uk - November 26 at 9:47 AM
Vectura to take big financial hit as VR475 fails to meed endpointVectura to take big financial hit as VR475 fails to meed endpoint
www.lse.co.uk - November 26 at 9:47 AM
Vectura drops severe asthma treatment after poor trial resultsVectura drops severe asthma treatment after poor trial results
finance.yahoo.com - November 26 at 9:47 AM
Vectura Group PLC (VEGPF) Global Agreement with Hikma to Develop Generic Versions of GSKs Ellipta Portfolio Conference (Transcript)Vectura Group PLC (VEGPF) Global Agreement with Hikma to Develop Generic Versions of GSK's Ellipta Portfolio Conference (Transcript)
seekingalpha.com - November 12 at 4:14 PM
UPDATE: Vecturas Flutiform Asthma Treatment Gets Positive OpinionUPDATE: Vectura's Flutiform Asthma Treatment Gets Positive Opinion
www.morningstar.co.uk - November 12 at 9:29 AM
LONDON MARKET PRE-OPEN: Sainsburys Profit Down; Hikma Ups GuidanceLONDON MARKET PRE-OPEN: Sainsbury's Profit Down; Hikma Ups Guidance
www.morningstar.co.uk - November 8 at 9:51 AM
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio 
finance.yahoo.com - November 8 at 9:51 AM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel